SERPINB3 and melanoma: Somatic mutations in SERPINB3, a gene encoding a protein of the serpin family of serine protease inhibitors, were reported to predict improved survival from treatment with anti-CTLA4 therapy in two independent cohorts of patients with melanoma [35].